Plus Therapeutics
PSTV
PSTV
12 hedge funds and large institutions have $118K invested in Plus Therapeutics in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
Holders
12
Holders Change
+5
Holders Change %
+71.43%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Millennium Management
New York
|
$26.5K |
| 2 |
HF
2
HRT Financial
New York
|
$15K |
| 3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$35.6K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$6.9K |
| 5 |
5
Citigroup
New York
|
$776 |
Top Sellers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$21.7K |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$1.94K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $35.6K | 26,543 | +9,536 | +56% |
|
|
2
Millennium Management
New York
| $26.5K | 19,749 | +19,749 | New |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| $21.7K | 16,197 | -56,664 | -78% |
|
|
HF
4
HRT Financial
New York
| $15K | 11,232 | +11,232 | New |
|
5
BlackRock
New York
| $9.33K | 6,960 | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $6.9K | 5,149 | +5,149 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $1.94K | 1,451 | -3,280 | -69% |
|
|
8
Citigroup
New York
| $776 | 579 | +579 | New |
|
9
Osaic Holdings
Scottsdale,
Arizona
| $178 | 133 | – | – |
|
10
Wells Fargo
San Francisco,
California
| $28 | 21 | +3 | +17% |
|
11
JPMorgan Chase & Co
New York
| $3 | 2 | +2 | New |
|
12
Group One Trading
Chicago,
Illinois
| $1 | 1 | – | – |
|
|
CFGS
13
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|